Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (56)

« Back to Publications

A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration.

Nguyen BT. et al, (2025), J Infect Dis, 231, e1080 - e1090

Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial.

Harris V. et al, (2025), Lancet Infect Dis, 25, 68 - 79

PROTEUS: a prospective RCT evaluating use of AI in stress echocardiography

Upton R. et al, (2024), New England Journal of Medicine, 1, 1 - 10

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.

Hobbs FR. et al, (2024), J Infect, 89

User engagement in clinical trials of digital mental health interventions: a systematic review.

Elkes J. et al, (2024), BMC Med Res Methodol, 24

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial.

Png ME. et al, (2024), Br J Gen Pract, 74, e570 - e579

A randomised controlled test in virtual reality of the effects on paranoid thoughts of virtual humans' facial animation and expression.

Wei S. et al, (2024), Sci Rep, 14

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes.

Hayward G. et al, (2024), J Infect, 88

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial.

Creswell C. et al, (2024), Lancet Psychiatry, 11, 193 - 209

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.

Kyle SD. et al, (2023), Lancet, 402, 975 - 987

PROTEUS Study: A Prospective Randomized Controlled Trial Evaluating the Use of Artificial Intelligence in Stress Echocardiography.

Woodward G. et al, (2023), Am Heart J, 263, 123 - 132

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.

Gbinigie O. et al, (2023), BMJ Open, 13

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study.

Stewart I. et al, (2023), Am J Respir Crit Care Med, 207, 693 - 703

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.

Butler CC. et al, (2023), Lancet, 401, 281 - 293

A randomised controlled trial to compare clinical and cost-effectiveness of an online parent-led treatment for child anxiety problems with usual care in the context of COVID-19 delivered in Child and Adolescent Mental Health Services in the UK (Co-CAT): a study protocol for a randomised controlled trial.

Taylor L. et al, (2022), Trials, 23

Load More